Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019 (COVID-19) breakthrough infections is unclear. We present the results of an observational prospective cohort study assessing and comparing COVID-19 progression in high-risk outpatients receiving mAb according t...

Full description

Bibliographic Details
Main Authors: Alessia Savoldi, Matteo Morra, Alessandro Castelli, Massimo Mirandola, Matilda Berkell, Mathias Smet, Angelina Konnova, Elisa Rossi, Salvatore Cataudella, Pasquale De Nardo, Elisa Gentilotti, Akshita Gupta, Daniele Fasan, Enrico Gibbin, Filippo Cioli Puviani, Jan Hasenauer, Roy Gusinow, Adriana Tami, Samir Kumar-Singh, Surbhi Malhotra-Kumar, mAb ORCHESTRA Working Group, Evelina Tacconelli
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
anti-spike monoclonal antibodies
COVID-19 breakthrough infection
COVID-19 early treatment
Online Access:https://www.mdpi.com/2227-9059/10/9/2063

Similar Items

Similar Items